KalVista Pharmaceuticals Inc. logo

KalVista Pharmaceuticals Inc. (KALV)

Market Closed
10 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
27. 00
0
0%
$
1.44B Market Cap
- P/E Ratio
- Div Yield
4.26M Volume
-2.92 Eps
$ 27
Previous Close
Add Transaction
Day Range
26.98 27
Year Range
9.83 27
Want to track KALV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

KalVista Pharmaceuticals Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
110 $1,604.84 $2,970 $1,365.16 85.07%
Kun Gao
Kun Gao Sherbrooke Park Advisers LLC
11,424 $139,144.29 $308,448 $169,303.71 121.67%
Kevin Kroskey
Kevin Kroskey True Wealth Design LLC
54 $623.25 $1,458 $834.75 133.94%
Bruce Barton
Bruce Barton Parkworth Wealth Management, Inc.
22 $249 $594 $345 138.55%
MWG
Martin Worley Group Martin Worley Group
10,168 $86,123 $274,536 $188,413 218.77%